In the red-hot world of marijuana stocks, there can be no question that GW Pharmaceuticals (NASDAQ:GWPH) reigns supreme. While most other marijuana-related stocks trade for pennies in the wild west of OTC markets, GW Pharmaceuticals trades on the Nasdaq at a market cap of roughly $2.5 billion.
However, as success always breeds competition, another clinical stage biotech is hot on GW’s heels. Could small-cap biotech Zogenix (NASDAQ:ZGNX) be the biggest threat to GW?